Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase II clinical trails for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of …
Over the last 12 months, insiders at Pluri Inc. have bought $0 and sold $0 worth of Pluri Inc. stock.
On average, over the past 5 years, insiders at Pluri Inc. have bought $6.65M and sold $1.89M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 80,616 shares for transaction amount of $145,109 was made by Aberman Zami (director) on 2022‑02‑10.
2022-12-20 | Sale | director | 2,000 0.0062% | $0.97 | $1,940 | -19.19% | ||
2022-02-10 | director | 80,616 0.4663% | $1.80 | $145,109 | -36.99% | |||
2021-05-28 | Sale | 10 percent owner | 115,007 1.3749% | $3.72 | $427,826 | -32.34% | ||
2021-05-27 | Sale | 10 percent owner | 95,885 1.137% | $3.69 | $353,816 | -31.97% | ||
2021-05-26 | Sale | 10 percent owner | 144,678 1.7117% | $3.68 | $532,635 | -32.25% | ||
2021-05-25 | Sale | 10 percent owner | 261,238 3.2238% | $3.84 | $1M | -31.32% | ||
2021-05-24 | Sale | 10 percent owner | 79,300 0.976% | $3.83 | $303,719 | -33.95% | ||
2021-05-21 | Sale | 10 percent owner | 69,838 0.8932% | $3.98 | $277,955 | -35.17% | ||
2021-05-03 | Sale | 10 percent owner | 23,721 0.3263% | $4.28 | $101,526 | -37.50% | ||
2021-04-30 | Sale | 10 percent owner | 166,004 2.486% | $4.66 | $773,579 | -37.03% | ||
2020-11-30 | 10 percent owner | 20,000 0.6234% | $9.70 | $194,000 | -60.93% | |||
2020-10-30 | 10 percent owner | 50,000 1.5281% | $9.51 | $475,500 | -54.05% | |||
2020-10-29 | 10 percent owner | 20,000 0.5913% | $9.20 | $184,000 | -53.92% | |||
2020-09-30 | 10 percent owner | 139,006 4.619% | $10.34 | $1.44M | -54.65% | |||
2020-09-29 | 10 percent owner | 60,123 1.8858% | $9.76 | $586,800 | -52.72% | |||
2020-09-28 | 10 percent owner | 13,189 0.4022% | $9.49 | $125,164 | -49.42% | |||
2020-09-24 | 10 percent owner | 34,800 1.0087% | $9.02 | $313,896 | -45.34% | |||
2020-09-23 | 10 percent owner | 10,734 0.3117% | $9.04 | $96,983 | -46.14% | |||
2020-07-31 | 10 percent owner | 14,536 0.4405% | $9.43 | $137,074 | -28.67% | |||
2020-07-30 | 10 percent owner | 51,235 1.5131% | $9.19 | $470,850 | -23.58% |
YANAY YAKY | Co-CEO & President | 4253045 76.5121% | $4.61 | 11 | 7 | +5.96% |
CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP | 10 percent owner | 3121918 56.1631% | $4.61 | 28 | 8 | <0.0001% |
MERETSKI SHAI | 10 percent owner | 2400000 43.1759% | $4.61 | 1 | 0 | |
Aberman Zami | director | 1491973 26.8405% | $4.61 | 13 | 8 | +1.24% |
BRAUN ISAAC | director | 636208 11.4453% | $4.61 | 1 | 0 | <0.0001% |